At the peak of antisemitism: Stanford University opens its doors to Israeli doctors
34 doctors and researchers from Ichilov and other Israeli institutions will undergo a two-year fellowship at Stanford's prestigious medical school. The program focuses on clinical training and joint research. Ichilov's CEO calls it a "huge badge of honor for Israeli medicine."
Against the backdrop of rising anti-Israel and antisemitic sentiment in global academic and medical circles, the Ichilov Medical Center in Tel Aviv and Stanford University in California have launched a unique and extensive collaboration.
Under this initiative, 34 doctors and researchers from Ichilov and other Israeli medical institutions are heading to Stanford’s medical school for advanced training. The program aims to foster joint research, accelerate medical innovation, and bring cutting-edge technologies back to Israel to enhance patient care.
The partnership was finalized several months ago by Prof. Eli Sprecher, director of Ichilov Hospital, and Stanford’s leadership. According to Prof. Sprecher, "This initiative places Israel, and Ichilov in particular, at the heart of the innovation network of one of the world's leading universities—precisely during a sensitive period for international academic collaboration."
The two-year program includes three tracks: short-term clinical fellowships, training in translational research, and full-year research tenures in Stanford laboratories, where participants will lay the groundwork for long-term collaborative projects.
Dr. Nurit Omer, deputy director of the neurology department at Ichilov, who is currently training at Stanford, says: "I chose to focus on the movement disorders unit under Prof. Kathleen Poston. The exchange is mutual; I was invited to lecture on our expertise in rare genetic diseases, and the Stanford team has shown great interest in our clinical approach and research infrastructure."
Prof. Dalit Ben-Yosef, head of the IVF laboratories at Ichilov, who recently returned from her fellowship, added: "It was an empowering experience. We established numerous partnerships that feel especially significant given the challenging times we have faced over the last two and a half years."
Prof. Eli Sprecher concluded: "The fact that a world-leading institution has chosen to open its doors to Israeli experts is a huge badge of honor for Israeli medicine. We are proud to lead this initiative and strengthen Israel’s status as a global medical powerhouse."
